Outcome	Q	df	I2 (95% CI)
Improvement in depression 0‐6	43.63	29	34 (0 to 57)
Improvement in depression 7‐12	42.32	12	72 (50 to 84)
Improvement in depression 13‐24	NA
Improvement in depression 0‐6 (cluster 0.00)	45.66	29	36 (1 to 59)
Improvement in depression 0‐6 (cluster 0.05)	42.99	29	33 (0 to 57)
Improvement in depression 0‐6 (SA cluster)	32.96	20	39 (0 to 64)
Improvement in depression 0‐6 (SA comorbidity)	31.18	22	29 (0 to 58)
Improvement in depression 0‐6 (ROB allocation)	15.87	13	18 (0 to 56)
Improvement in depression 0‐6 (ROB attrition)	39.54	26	34 (0 to 59)
Improvement in depression 0‐6 (intervention length)	4.47	5	0 (0 to 75)
Depression response 0‐6	161.34	47	71 (61 to 78)
Depression response 7‐12	161.68	28	83 (76 to 87)
Depression response 13‐24	4.29	5	0 (0 to 75)
Depression response 25+	0.64	4	0 (0 to 79)
Depression response 0‐6 (cluster 0.00)	165.19	47	72 (62 to 79)
Depression response 0‐6 (cluster 0.05)	154.47	47	70 (59 to 77)
Depression response 0‐6 (SA cluster)	149.53	38	75 (65 to 81)
Depression response 0‐6 (SA comorbidity)	123.79	36	71 (59 to 79)
Depression response 0‐6 (ROB allocation)	90.28	21	77 (65 to 85)
Depression response 0‐6 (ROB attrition)	135.70	34	75 (65 to 82)
Depression response 0‐6 (intervention length)	15.53	10	36 (0 to 68)
AD use 0‐6	232.05	43	81 (76 to 86)
AD use 7‐12	111.31	25	78 (67 to 84)
AD use 13‐24	10.85	5	54 (0 to 82)
AD use 25+	1.59	2	0 (0‐90)
Improvement in anxiety symptoms 0‐6	NA	NA	NA
Improvement in anxiety symptoms 7‐12	NA	NA	NA
Improvement in anxiety symptoms 13‐24	NA	NA	NA
Anxiety response 0‐6	6.71	3	55 (0 to 85)
Anxiety response 7‐12	9.47	4	58 (0 to 84)
Anxiety response 13‐24	NA
Anxiety medication use 0‐6	4.54	2	56 (0 to 87)
Anxiety medication use 7‐12	0.91	3	0 (0 to 85)
Anxiety medication use 13‐24	NA
Mental QOL 0‐6	53.87	13	76 (59 to 86)
Mental QOL 7‐12	23.93	10	58 (18 to 79)
Mental QOL 13‐24	4.1	2	51 (0 to 86)
Mental QOL 25+	0	1	NA
Physical QOL 0‐6	4.92	9	0 (0 to 62)
Physical QOL 7‐12	27.47	9	67 (36 to 83)
Physical QOL 13‐24	1.19	3	0 (0 to 85)
Patient satisfaction (cont) 0‐6	50.38	9	82 (68 to 90)
Patient satisfaction (dichot) 0‐6	92.42	23	75 (63 to 83)
Improvement in depression 0‐6 (adol)	0.14	1	NA
Improvement in depression 7‐12 (adol)	NA
Depression response 0‐6 (adol)	0.2	1	NA
Depression response 7‐12 (adol)	1.47	1	NA
Depression response 13‐24 (adol)	NA	NA	NA
AD use 0‐6 (adol)	NA	NA	NA
AD use 7‐12 (adol)	NA	NA	NA
AD use 13‐24 (adol)	NA	NA	NA
Mental QoL 0‐6 (adol)	0.00	1	NA
Mental QoL 7‐12 (adol)	1.89	1	NA
Mental QoL 13‐24 (adol)	NA	NA	NA
Physical QoL 0‐6 (adol)	NA	NA	NA
Physical QoL 7‐12 (adol)	NA	NA	NA
Satisfaction (adol)	5.44	1	NA
Feedback Depression 0‐6	NA	NA	NA
Feedback Depression response 0‐6	NA	NA	NA
Feedback Depression response 7‐12	NA	NA	NA
CL Depression response 0‐6	NA	NA	NA
CL Depression response 25+	NA	NA	NA
ESR Depression 0‐6	NA	NA	NA
PT+CC v meds Depression response 0‐6	NA	NA	NA
PT +CC v meds Depression response 7‐12	NA	NA	NA
PT+CC v meds Depression response 13‐24	NA	NA	NA
PT+CC v meds Depression response 25+	NA	NA	NA
PT+CC v CC Depression symptoms 0‐6	0.00	1	NA
PT+CC v CC Depression response 7‐12	NA	NA	NA
PT+CC v CC Depression response 25+	NA	NA	NA